TOGA ASM 2024 Charting New Horizons: A Multidsiciplinary Approach to Lung Cancer screening and Care


Get ready to be immersed in research, new findings, and connect with professionals from all areas of healthcare.




Find out about the international and local speakers delivering sessions rich with insights and practical takeaways in thoracic oncology. 


Abstract Submissions

Contribute to the development of lung cancer care through an abstract and be included in the program.

See More

International Speakers

Philip Crosby headshot, standing in hallway of hospital

Professor Philip Crosbie

We are privileged to welcome Professor Philip Crosbie from the University of Manchester as our international speaker at the TOGA 2024 ASM.

Phil is a Senior Lecturer and Honorary Consultant in Respiratory Medicine at the University of Manchester. His main clinical and research interest is lung cancer with a specific focus on early detection and screening.

Join us at the ASM where he will share his expertise and valuable insights into the UK’s experience with lung cancer screening.

Professor Myung-Ju Ahn, M.D.

It is our pleasure to welcome Professor Myung-Ju Ahn to the 2024 TOGA ASM. She is from the Department of Medicine, Sungkyunkwan University School of Medicine in Seoul.

Myung-Ju has focused on early clinical trials for the development of drug discovery and repurposing of targeted drugs and the development of a NSCLC genome atlas.

Attend her session ‘Treatment Strategies to Overcome Osimertinib Resistance’ and her presentation on small cell lung cancer updates.

Jessica Donington, MD, MSCR

Dr. Donington is the Professor of Surgery and Chief of the Section of Thoracic Surgery at the University of Chicago. 

She has expertise in multimodality therapy for locally advanced lung cancer, lung cancer clinical trials, and treatment for medically high-risk patients early-stage lung cancer. 

Join her at the ASM where she will speak on ‘Resectable Lung Cancer & IO’ and ‘Novel Indications for Surgery in Advanced Stage Lung Cancer’. 

Convenor Message

Portrait of Tracy Leong

“It is my absolute honour and delight to convene the TOGA ASM for 2024 which will promote ‘Charting New Horizons: A Multidisciplinary Approach to Lung Cancer Screening and Care’.

At this exciting time of advances in the field of lung cancer, the TOGA ASM represents a key meeting to learn from international and national experts, develop collaborations with colleagues, and connect with valued members of the lung cancer community.

Together with a stellar multi-disciplinary organising team, I greatly look forward to welcoming you in August to inspire and be inspired.”

Dr Tracy Leong MBBS (Hons) FRACP MPH PhD CCPU SpecCertClinLead
Director of Bronchoscopy, Respiratory and Sleep Physician, Austin Health
ASM Convenor

What you should know about TOGA ASM 2024

The TOGA ASM will provide an opportunity for our multidisciplinary membership to come together to learn of the advances in quality thoracic cancer care, to discuss their application in the local healthcare environment, and to develop cross-cutting research capacity.

The three-day meeting program will cover topical areas of thoracic cancer treatment and research, as well as feature local and international speakers.

This year’s program highlights the National Lung Cancer Screening Program (LCSP) implementation, and the changes lung cancer screening will bring to each of the major clinical disciplines involved in quality lung cancer care.

Oral abstract sessions will provide an opportunity for members to present their research. This will enable progress as TOGA was established to be outlined and invite members to engage with the TOGA leadership.

The meeting will provide an opportunity to connect and collaborate with some of the most innovative and influential minds in healthcare and clinical research.

From respiratory medicine, medical oncology, radiation oncology, surgery, pathology, nursing, allied health, and consumers you will have the opportunity to engage with everyone across the lung cancer community. 

The key dates leading up to the ASM are: 

  •       Abstract submissions open: March 2024
  •       Abstract submission deadline: 6 May 2024
  •       Registration and hotel accommodation open: 2 May 2024
  •       Abstract notifications of acceptance/rejection: mid-June 2024
  •       Oral presenters bio & photo deadline: 17 June 2024
  •       Presenting author registration deadline: 15 July 2024
  •       Registration and hotel accommodation booking deadline: 15 July 2024
  •       Oral presenters PowerPoint Presentation deadline: 24 July 2024
  •       ASM: 31 July – 2 August 2024

Thank you to our Sponsors

Platinum Sponsor

Gold Sponsor

Silver Sponsors

Bronze Sponsors

The TOGA 2024 ASM offers a tremendous opportunity to market to one of the largest gatherings of researchers, clinicians, and professionals in the field of lung cancer and thoracic oncology across Australasia. The meeting provides broad company profiling, networking with lead clinicians, and opportunities for future research collaborations.

For more information regarding sponsorship opportunities, please contact:
Dilu Uduwela
Events Manager